Thursday, 20 March 2025

Rheumatoid Arthritis: Unravelling the Pathophysiology 🧬

πŸ‘‹ Let’s dive into the fascinating (and complex) world of Rheumatoid Arthritis (RA)—a classic autoimmune disorder that’s important to understand for future clinical practice. πŸ©ΊπŸ“š


As always, understanding the pathophysiology helps to make it all make sense. 

πŸ” What’s happening in RA?

RA is a chronic, systemic inflammatory disease primarily targeting the synovial joints. But it’s not just about joints—it’s a whole-body condition! Here’s the breakdown:

1️⃣ Loss of Immune Tolerance: The Root of the Problem

In RA, the immune system loses its ability to distinguish "self" from "non-self." Here’s how it happens:

πŸ‘‰ Citrullination: Under stress or inflammation, proteins in the synovium (like vimentin and fibrin) undergo post-translational modification (citrullination). This process converts arginine residues into citrulline, creating "neo-antigens."

πŸ‘‰ Autoantibodies: In genetically predisposed individuals (e.g., HLA-DR4), immune cells recognize these citrullinated proteins as foreign. This triggers the production of anti-citrullinated protein antibodies (ACPAs) and rheumatoid factor (RF).

πŸ‘‰ Breakdown of Tolerance: Normally, regulatory T-cells (Tregs) keep autoimmunity in check. In RA, this regulation fails, leading to uncontrolled activation of T-helper cells (Th1 and Th17) and B-cells, which drive the inflammatory cascade.


2️⃣ Synovial Inflammation: The Joint Under Attack

The synovium is the primary battleground in RA. Here’s what’s happening inside the joint:

πŸ‘‰ Immune Cell Infiltration:

  • T-cells (especially CD4+ Th1 and Th17 cells) migrate to the synovium, releasing pro-inflammatory cytokines like IFN-Ξ³ and IL-17.
  • B-cells produce autoantibodies (RF and ACPAs), which form immune complexes that further activate the immune system.
  • Macrophages are activated by cytokines and release more inflammatory mediators like TNF-Ξ±, IL-1, and IL-6.

πŸ‘‰ Synovial Hyperplasia:

  • The synovial lining thickens due to the proliferation of synovial fibroblasts and infiltration of immune cells.
  • This forms a pannus—a destructive, tumor-like tissue that invades cartilage and bone.

πŸ‘‰ Cytokine Storm:

  • TNF-Ξ± and IL-1 drive inflammation, while IL-6 contributes to systemic symptoms (e.g., fatigue, anemia).
  • These cytokines also activate osteoclasts, which break down bone, and matrix metalloproteinases (MMPs), which degrade cartilage.


3️⃣ Joint Destruction: The End Result

The pannus and inflammatory cascade lead to irreversible joint damage:

πŸ‘‰ Cartilage Destruction: MMPs break down collagen and proteoglycans in the cartilage, leading to joint space narrowing.

πŸ‘‰ Bone Erosion: Osteoclasts resorb bone, causing erosions visible on X-rays.

πŸ‘‰ Joint Deformities: Chronic inflammation weakens tendons and ligaments, leading to classic deformities like:

  • Swan neck deformity (hyperextension of PIP joint, flexion of DIP joint)
  • BoutonniΓ¨re deformity (flexion of PIP joint, hyperextension of DIP joint)
  • Ulnar deviation of the fingers


4️⃣ Systemic Effects: Beyond the Joints

RA isn’t just about joints! It can cause fatigue, fever, and extra-articular manifestations like:

πŸ‘‰ Rheumatoid nodules (firm, non-tender subcutaneous nodules, often over pressure points)

πŸ‘‰ Pleuritis, pericarditis (inflammation of the pleura or pericardium)

πŸ‘‰ Vasculitis (inflammation of blood vessels)

πŸ‘‰ Interstitial lung disease (progressive lung fibrosis)

πŸ‘‰ Felty’s syndrome (RA + splenomegaly + neutropenia)



πŸ’‘ Key Takeaways:

πŸ‘‰ RA starts with loss of immune tolerance, driven by citrullination, autoantibodies, and cytokine dysregulation.

πŸ‘‰ The synovium is the primary site of inflammation, leading to pannus formation and joint destruction.

πŸ‘‰ Early diagnosis and aggressive treatment with DMARDs (e.g., methotrexate) and biologics (e.g., TNF inhibitors) are crucial to prevent irreversible damage.

πŸ‘‰ Don’t forget the HLA-DR4 association and the role of ACPAs in diagnosis!

πŸ“š Study Tip:

πŸ‘‰ Link RA’s pathophysiology to its clinical presentation and treatment. Understanding the “why” behind the disease will make it stick!

No comments:

Post a Comment